Kiniksa Pharmaceuticals International
KNSA | NASDAQ
$78.28
+$0.15 (+0.19%)
Sep 22, 2026, 1:36 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 840.85M | 754.05M | 677.56M | 597.97M | 529.33M | 481.17M | 423.24M | 384.1M | 338.93M | 301.77M | 270.26M | 248.75M | 280.84M | 236.34M | 220.18M | 177.04M | 90M | 70.73M | 38.54M | 19.8M | 7.7M | n/a |
Cost of Revenue | 294.63M | 342.08M | 307.37M | 282.44M | 248.27M | 219.7M | 189.58M | 150.17M | 128.15M | 108.44M | 93.36M | 80.83M | 65.94M | 52.99M | 50.11M | 39.74M | 31.07M | 24.76M | 12.07M | 8.21M | 4.37M | 883K |
Gross Profit | 546.22M | 411.95M | 370.19M | 315.52M | 281.05M | 261.46M | 233.66M | 233.93M | 210.78M | 193.33M | 176.9M | 167.92M | 214.9M | 183.34M | 170.08M | 137.3M | 58.93M | 45.98M | 26.47M | 11.59M | 3.34M | -883K |
Operating Income | 100.25M | 93.22M | 77.22M | 38.15M | 4.48M | -15.8M | -45.62M | -26.24M | -27.51M | -30.54M | -25.2M | -19.23M | 38.11M | 21.9M | 9.77M | -32.41M | -109.49M | -130.67M | -156.64M | -173.4M | -185.95M | -177.26M |
Interest Income | 13.22M | 11.98M | 10.86M | 10.47M | 9.79M | 9.49M | 7.2M | 7.25M | 7.22M | 6.71M | 10.38M | 8.8M | 6.7M | 4.88M | 1.25M | 536K | 219K | 122K | 97K | 50K | 94K | 354K |
Pretax Income | 114.25M | 105.98M | 88.87M | 48.62M | 14.26M | -6.31M | -36.15M | -16.72M | -18.02M | -21.56M | -16.65M | -12.26M | 42.97M | 24.95M | 11.03M | -31.87M | -109.27M | -130.55M | -156.54M | -173.35M | -185.86M | -176.91M |
Net Income | 80.66M | 73.06M | 59.01M | 35.92M | 4.79M | -16.95M | -43.19M | -9.07M | -10.23M | 8.65M | 14.08M | -6.69M | 231.26M | 196.3M | 183.36M | 142.57M | -112.07M | -133.65M | -157.92M | -175.25M | -188.54M | -184.45M |
Selling & General & Admin | 230.9M | 213.89M | 196.27M | 180.03M | 177.33M | 172.86M | 168.01M | 164.22M | 151.58M | 137.59M | 127.11M | 117.59M | 107.73M | 102.42M | 95.7M | 91.22M | 87.38M | 85.53M | 84.05M | 76.81M | 68.55M | 56.84M |
Research & Development | 127.15M | 105M | 96.85M | 97.34M | 99.26M | 104.41M | 111.26M | 95.95M | 86.71M | 86.29M | 74.99M | 69.56M | 69.06M | 59.03M | 64.6M | 77.65M | 80.2M | 90.28M | 98.22M | 108.18M | 120.74M | 119.53M |
Other Expenses | 88.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 835K | 835K | 835K | 835K | n/a | n/a | n/a |
Operating Expenses | 445.97M | 318.75M | 292.98M | 277.38M | 276.59M | 277.27M | 279.27M | 260.17M | 238.29M | 223.87M | 202.1M | 187.15M | 176.79M | 161.45M | 160.3M | 169.71M | 168.41M | 176.65M | 183.11M | 185M | 189.29M | 176.38M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.83M | 1.83M | 1.83M | 1.83M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 740.6M | 660.83M | 600.34M | 559.82M | 524.86M | 496.97M | 468.86M | 410.33M | 366.44M | 332.31M | 295.46M | 267.98M | 242.73M | 214.44M | 210.41M | 209.45M | 199.49M | 201.41M | 195.18M | 193.2M | 193.66M | 177.26M |
Income Tax Expense | 33.59M | 32.93M | 29.86M | 12.7M | 9.47M | 10.64M | 7.04M | -7.66M | -7.79M | -30.21M | -30.74M | -5.57M | -188.28M | -171.36M | -172.34M | -174.44M | 2.8M | 3.1M | 1.39M | 1.9M | 2.68M | 7.54M |
Shares Outstanding (Basic) | 77.58M | 76.52M | 74.2M | 73.61M | 73.44M | 72.65M | 72.32M | 71.73M | 71M | 70.63M | 70.37M | 70.19M | 69.92M | 69.75M | 69.61M | 69.45M | 68.9M | 69.14M | 68.97M | 68.66M | 68.14M | 68.27M |
Shares Outstanding (Diluted) | 83.4M | 82.41M | 78.98M | 78.03M | 77.94M | 76.15M | 72.32M | 71.73M | 71M | 70.63M | 72.66M | 70.19M | 71.63M | 69.75M | 71.37M | 70.55M | 69.29M | 69.14M | 68.97M | 68.66M | 68.4M | 68.27M |
EPS (Basic) | 1.07 | 0.98 | 0.80 | 0.49 | 0.06 | -0.23 | -0.60 | -0.12 | -0.15 | 0.12 | 0.19 | -0.11 | 3.32 | 2.82 | 2.64 | 2.05 | -1.62 | -1.94 | -2.30 | -2.56 | -2.78 | -2.82 |
EPS (Diluted) | 0.98 | 0.91 | 0.75 | 0.45 | 0.04 | -0.24 | -0.60 | -0.13 | -0.16 | 0.11 | 0.18 | -0.11 | 3.27 | 2.77 | 2.59 | 2 | -1.62 | -1.94 | -2.30 | -2.56 | -2.78 | -2.82 |
EBITDA | 112.09M | 107.66M | 90.42M | 50.11M | 15.76M | -4.74M | -34.46M | -15.19M | -15.89M | -18.8M | -13.23M | -7.99M | 47.2M | 29.2M | 15.25M | -28.06M | -105.33M | -126.7M | -152.9M | -169.84M | -182.82M | -174.56M |
EBIT | 110.3M | 105.98M | 88.87M | 48.62M | 14.26M | -6.31M | -36.15M | -16.72M | -18.02M | -21.56M | -16.65M | -12.26M | 42.97M | 24.95M | 11.03M | -31.87M | -109.27M | -130.55M | -156.54M | -173.38M | -185.94M | -177.25M |
Depreciation & Amortization | 1.79M | 1.68M | 1.55M | 1.49M | 1.5M | 1.57M | 1.7M | 1.53M | 2.13M | 2.76M | 3.43M | 4.27M | 4.22M | 4.26M | 4.22M | 3.81M | 3.93M | 3.85M | 3.64M | 3.54M | 3.12M | 2.69M |
Add to Watchlist
Select watchlists to add or remove KNSA